Slideshow

Impact of Canagliflozin on Renoprotection in T2DM

Author(s):

Veronica Hackethal MD

Will SGLT2 inhibitor canagliflozin prove renoprotective in T2DM patients? CANVAS study authors sought to find out.

Related Videos
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Related Content
Semaglutide 7.2 mg Exhibits 20.7% Weight Loss in Phase 3b STEP UP Trial | Image Credit: Novo Nordisk
January 17th 2025

Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial

Connor Iapoce
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Serum Uric Acid Levels Linked to Risk of Dyslipidemia in Type 2 Diabetes | Image Credit: National Cancer Institute
January 7th 2025

Serum Uric Acid Levels Linked to Risk of Dyslipidemia in Type 2 Diabetes

Connor Iapoce
Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas | Image Credit: HCPLive
January 6th 2025

Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
GLP-1 RA Discontinuations Frequent in People with Obesity Without Diabetes| Image Credit: Kenny Eliason/Unsplash
January 3rd 2025

GLP-1 RA Discontinuations Frequent in People with Obesity Without Diabetes

Connor Iapoce
HCPLive Endocrinology Year in Review 2024
January 1st 2025

Endocrinology Year in Review: 2024

Patrick Campbell
© 2025 MJH Life Sciences

All rights reserved.